NDC 0169-3003-01 - Novolin R
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0169-3003
- Requested NDC
- 0169-3003-01
- Package NDCs from labels
- 0169-3003-01, 0169-3003-15, 0169-3003-12, 0169-3003-25
- Manufacturer
- Novo Nordisk
- Effective date
- 2022-11-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Novolin R - Novo Nordisk | Novo Nordisk | 2022-11-23 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0169-3003-01 | NovolinR | 3 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 3 | 19 | |
| 0169-3003-12 | NovolinR | 3 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 3 | 19 | |
| 0169-3003-15 | NovolinR | 5 in 1 CARTON | INJECTION, SOLUTION | 5 | 19 | |
| 0169-3003-25 | NovolinR | 5 in 1 CARTON | INJECTION, SOLUTION | 5 | 19 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0169-3003-01 | ML - Milliliter | 0169-3003 | 476b3f63-aa36-4fed-9ed4-21549f6e3b10 | 1 | 2021-04-08 |
| 0169-3003-12 | ML - Milliliter | 0169-3003 | 4b0b8f92-b40a-4627-9199-59fd02f0cf98 | 1 | 2022-06-06 |
| 0169-3003-15 | ML - Milliliter | 0169-3003 | 95639287-ef66-4d48-9d5f-cb16b204833a | 1 | 2020-01-03 |
| 0169-3003-25 | ML - Milliliter | 0169-3003 | 653bc94f-b955-47ac-830e-17376b766640 | 1 | 2020-01-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | NOVOLIN R (HUMAN INSULIN) INJECTION, SOLUTION [NOVO NORDISK] | 12 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | NOVOLIN R (HUMAN INSULIN) INJECTION, SOLUTION [NOVO NORDISK] | 12 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | NOVOLIN R (HUMAN INSULIN) INJECTION, SOLUTION [NOVO NORDISK] | 12 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | NOVOLIN R (HUMAN INSULIN) INJECTION, SOLUTION [NOVO NORDISK] | 12 | |
| METACRESOL | INACTIVE INGREDIENT | GGO4Y809LO | NOVOLIN R (HUMAN INSULIN) INJECTION, SOLUTION [NOVO NORDISK] | 12 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | NOVOLIN R (HUMAN INSULIN) INJECTION, SOLUTION [NOVO NORDISK] | 12 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | NOVOLIN R (HUMAN INSULIN) INJECTION, SOLUTION [NOVO NORDISK] | 12 | |
| ZINC CHLORIDE | INACTIVE INGREDIENT | 86Q357L16B | NOVOLIN R (HUMAN INSULIN) INJECTION, SOLUTION [NOVO NORDISK] | 12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AM-13 | CARBON DISULFIDE, SILVER NITRATE, CORALLIUM RUBRUM WHOLE, CUPRIC ARSENITE, ASIAN GINSENG, HYPERICUM PERFORATUM, LATHYRUS SATIVUS WHOLE, PICRIC ACID, SELENIUM, DATURA STRAMONIUM WHOLE, AND ZINC | DNA Labs, Inc. | 735d1d54-dd9d-4867-bfdf-3003d7403953 | 2025-01-09 | Warnings | J41CSQ7QDS |
| N-17 | ZINC, SELENIUM, BOS TAURUS THYMUS, SUS SCROFA SPLEEN, BOS TAURUS LYMPH, BOS TAURUS ADRENAL GLAND, ARGININE, CYSTINE, ECHINACEA ANGUSTIFOLIA, THIAMINE, PYRIDOXINE HYDROCHLORIDE, AND ASCORBIC ACID | DNA Labs, Inc. | a6a13048-b1b4-4a46-acad-d379d4e4b6fb | 2025-01-09 | Warnings | J41CSQ7QDS |
| T-27 | WATER | DNA Labs, Inc. | f0e9afd7-64a4-4b85-9c5f-4bf07ba4b481 | 2025-01-09 | Warnings | 059QF0KO0R |
| Hemorrhoidal Cream with Aloe | GLYCEROL, PHENYLEPHINE, PRAMOXINE, PETROLATUM | Chain Drug Marketing Association | 2b33c710-ac17-20f9-e063-6294a90ad29c | 2025-01-08 | Warnings | PDC6A3C0OX |
| ANTIBACTERIAL DREAMY FLORALS | GLYCERIN | Quimicas Handal de Centroamerica SA de CV | 09f73bec-516d-90f0-e063-6394a90aecab | 2025-01-08 | Warnings | PDC6A3C0OX |
| Sterile Water | STERILE WATER FOR INJECTION | Medefil, Inc. | 99e99a50-82d5-aff6-e053-2a95a90a8c56 | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| BACTERIOSTATIC WATER | BACTERIOSTATIC WATER | HF Acquisition Co LLC, DBA HealthFirst | 99b0ef9b-600a-40dc-e053-2a95a90aa07e | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 99b1cb12-0b2d-0c0f-e053-2a95a90ac3b6 | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| NativeRemedies Tic Tamer | CHAMOMILLA, CINA, HYOSCYAMUS, ZINC MET | Silver Star Brands | f76c2b90-d5fa-e765-e053-6394a90af57f | 2025-01-01 | Warnings | J41CSQ7QDS |
| Epi-Still-M | CICUTA VIROSA, CUPRUM METALLICUM, IGNATIA AMARA, PASSIFLORA INCAMATA, SCUTELLARIA LATERIFLORA, ZINCUM METALLICUM | Silver Star Brands | 4148cf33-e109-19d8-e054-00144ff88e88 | 2025-01-01 | Warnings | J41CSQ7QDS |
| Stress Away Anxiety Relief | ACONITUM NAP, ALFALFA, AVENA, CHAMOMILLA, GELSEMIUM, HUMULUS IUPULUS, IGNATIA, KALI ARS, KALI PHOS, MURIATICUM AC, NAT PHOS, PASSIFLORA, PHOSPHORUS, STAPHYSAGRIA, STRAMONIUM | Silver Star Brands | 05e04129-e7c1-4e11-e063-6394a90a09ca | 2025-01-01 | Warnings | QTT17582CB |
| Prevention Oncology Mouth Rinse | GLYCERIN | Prevention Health Sciences, Inc. | 1ec9ed1c-bcb6-3a0a-e054-00144ff8d46c | 2025-01-01 | Warnings | PDC6A3C0OX |
| CLENZIDERM THERAPEUTIC MOISTURIZER | GLYCERIN | Obagi Cosmeceuticals LLC | d60e22e3-831e-4787-a82c-e7763c287553 | 2025-01-01 | Warnings | PDC6A3C0OX |
| Tucks Triple Relief Hemorrhoidal | WHITE PETROLATUM, GLYCERIN, PRAMOXINE HYDROCHLORIDE, AND PHENYLEPHRINE HYDROCHLORIDE | Blistex Inc. | bf892e90-2d9b-4fa0-8ee4-8a2736be6c30 | 2024-12-24 | Warnings | PDC6A3C0OX |
| Pedia-Lax | GLYCERIN | C.B. Fleet Company, Inc. | 4e15f6ca-a40c-485f-be3f-07c2ed7cb498 | 2024-12-23 | Warnings | PDC6A3C0OX |
| OASIS Tears Preservative-Free Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | d9d71b1d-82a6-42e7-9ef2-2d041daef936 | 2024-12-23 | Warnings | PDC6A3C0OX |
| DCH Hemorrhoidal | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0050701f-4393-3f01-e063-6394a90a4e0e | 2024-12-19 | Warnings | PDC6A3C0OX |
| Revivol Hemorrhoid and Fissure | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0140cf68-b6a0-4378-e063-6394a90afee8 | 2024-12-19 | Warnings | PDC6A3C0OX |
| RECTICARE | LIDOCAINE AND GLYCERIN | Ferndale Laboratories, Inc. | 2b94136a-4975-2925-e054-00144ff88e88 | 2024-12-17 | Warnings | PDC6A3C0OX |
| Fendall Pure Flow | PURIFIED WATER | Honeywell Safety Products USA, Inc. | afda6fc3-7615-b0be-e053-2995a90a6208 | 2024-12-10 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.